GE HealthCare has partnered with radiation therapy company Elekta to develop new software to improve clinicians experience and enable greater precision treatment. Elekta will use GE HealthCare’s MIM Software imaging management platform, which GE HealthCare…
Continue Reading
GE HealthCare has partnered with radiation therapy company Elekta to develop new software to improve clinicians experience and enable greater precision treatment. Elekta will use GE HealthCare’s MIM Software imaging management platform, which GE HealthCare…
Continue Reading
Cambron Carter, Co-founder and Chief Technology Officer at Pearl
The synergy of artificial intelligence (AI) and medical imaging has opened new horizons for healthcare. AI-mediated computer vision has been in use in oncology for more…
Continue Reading
What You Should Know:
– AccessHope, a company revolutionizing how cancer patients receive cutting-edge treatment plans secures $33M in a Series B funding round led by City of Hope, a prominent cancer research and treatment…
Continue Reading
What You Should Know:
– Just weeks after acquiring MIM Software, a leader in medical imaging analysis and AI solutions, GE HealthCare strengthens its commitment to improving cancer care through a deeper collaboration with Elekta,…
Continue Reading
What You Should Know:
– COTA, a leading real-world data (RWD) and analytics company in oncology, has announced a new collaboration with Sanofi.
– The strategic partnership aims to leverage RWD and artificial intelligence (AI) to…
Continue Reading
What You Should Know:
– VieCure, a leading cancer care company, announced today that it’s integrating DrFirst’s e-prescribing and medication management solutions into its clinical decision support system.
– VieCure is a well-established point-of-care intelligence system…
Continue Reading
By Shania Kennedy
April 08, 2024 – Machine learning tools can accurately forecast an unplanned hospitalization event during concurrent chemoradiotherapy (CRT) using patient-generated health data from wearable devices, according to a study published recently in JAMA…
Continue Reading
What You Should Know: – PreciseDx®, a leader in AI-powered diagnostics for oncology, announces a crucial collaboration with UCLA’s Department of Pathology and Laboratory Medicine. – The research initiative focuses on evaluating PreciseDx’s innovative…
Continue Reading
What You Should Know:
Culmination Bio, a data and technology company combining clinical and biospecimen data, announced a partnership with BillionToOne, Inc., a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that…
Continue Reading
